These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 26839369
1. Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny. Chen Y, Zane NR, Thakker DR, Wang MZ. Drug Metab Dispos; 2016 Jul; 44(7):975-83. PubMed ID: 26839369 [Abstract] [Full Text] [Related]
3. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli. Rettie AE, Lawton MP, Sadeque AJ, Meier GP, Philpot RM. Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899 [Abstract] [Full Text] [Related]
4. Quinuclidine N-Oxygenation Mediated by Flavin-Containing Monooxygenases 1 and 3 in Kidney and Liver Microsomes from Humans, Monkeys, Dogs, and Pigs. Shimizu M, Makiguchi M, Uno Y, Yamazaki H. Drug Metab Dispos; 2024 Jul 16; 52(8):906-910. PubMed ID: 38769015 [Abstract] [Full Text] [Related]
5. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity. Störmer E, Roots I, Brockmöller J. Br J Clin Pharmacol; 2000 Dec 16; 50(6):553-61. PubMed ID: 11136294 [Abstract] [Full Text] [Related]
6. Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity. Krause RJ, Lash LH, Elfarra AA. J Pharmacol Exp Ther; 2003 Jan 16; 304(1):185-91. PubMed ID: 12490590 [Abstract] [Full Text] [Related]
7. Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Overby LH, Carver GC, Philpot RM. Chem Biol Interact; 1997 Aug 29; 106(1):29-45. PubMed ID: 9305407 [Abstract] [Full Text] [Related]
11. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics. Gröer C, Busch D, Patrzyk M, Beyer K, Busemann A, Heidecke CD, Drozdzik M, Siegmund W, Oswald S. J Pharm Biomed Anal; 2014 Nov 29; 100():393-401. PubMed ID: 25218440 [Abstract] [Full Text] [Related]
15. Molecular and functional characterization of flavin-containing monooxygenases in cynomolgus macaque. Uno Y, Shimizu M, Yamazaki H. Biochem Pharmacol; 2013 Jun 15; 85(12):1837-47. PubMed ID: 23623750 [Abstract] [Full Text] [Related]
17. Cloning and sequencing of flavin-containing monooxygenases FMO3 and FMO4 from rabbit and characterization of FMO3. Burnett VL, Lawton MP, Philpot RM. J Biol Chem; 1994 May 13; 269(19):14314-22. PubMed ID: 8188717 [Abstract] [Full Text] [Related]
18. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. Lang DH, Rettie AE. Br J Clin Pharmacol; 2000 Oct 13; 50(4):311-4. PubMed ID: 11012553 [Abstract] [Full Text] [Related]
19. Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5. Cherrington NJ, Cao Y, Cherrington JW, Rose RL, Hodgson E. Xenobiotica; 1998 Jul 13; 28(7):673-82. PubMed ID: 9711811 [Abstract] [Full Text] [Related]